HLAG CLIA Kit

Catalog No. ABIN5668595

Product Details HLAG CLIA Kit

Target: HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

Reactivity: Human

Detection Method: Chemiluminescent

Method Type: Sandwich ELISA

Detection Range: 0.16 ng/mL - 10 ng/mL

Minimum Detection Limit: 0.16 ng/mL

Application: ELISA

Analytical Method: Quantitative

Sensitivity: 0.09 ng/mL

Components: - Micro CLIA Plate
- Reference Standard
- Concentrated Biotinylated Detection Ab (100×)
- Concentrated HRP Conjugate (100×)
- Reference Standard & Sample Diluent
- Biotinylated Detection Ab Diluent
- HRP Conjugate Diluent
- Concentrated Wash Buffer (25×)
- Substrate Reagent A
- Substrate Reagent B
- Plate Sealer
- Product Description
- Certificate of Analysis

Application Details

Plate: Pre-coated

Restrictions: For Research Use only

Handling

Storage: 4 °C,-20 °C

Storage Comment: The unopened kit can be stored at 4 ℃ for 1 week. If the kit is not used within 1 week, store the items separately according to the special conditions since the kit is received.

Target Details

Target: HLAG (HLA Class I Histocompatibility Antigen, alpha Chain G (HLAG))

Alternative Name: Major Histocompatibility Complex Class I G (HLAG Products)

Synonyms: MHC-G CLIA Kit, B-F CLIA Kit, B-F-S04 CLIA Kit, B-F-S05 CLIA Kit, B-F-S06 CLIA Kit, B-F-S07 CLIA Kit, B-FI CLIA Kit, B-FIV CLIA Kit, BF2 CLIA Kit, BFa2 CLIA Kit, BFw-03 CLIA Kit, BFw-05 CLIA Kit, BFz-01 CLIA Kit, major histocompatibility complex, class I, G CLIA Kit, MHC BF1 class I CLIA Kit, HLA-G CLIA Kit, BF1 CLIA Kit

Background: Alternative Names: HLA-G5, MHC-G

Pathways: Regulation of Leukocyte Mediated Immunity, Positive Regulation of Immune Effector Process, Cancer Immune Checkpoints